Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Taylor

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Vaccine|May 13, 2008
Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidateRobin McKenzie, Malabi M Venkatesan, Marcia K Wolf, et al.
Vaccine|July 17, 2012
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune responseDavid N Taylor, John J Treanor, Eric A Sheldon, et al.
Infection and Immunity|March 16, 2002
Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccineMitchell B Cohen, Ralph A Giannella, Judy Bean, et al.
Infection and Immunity|January 27, 2004
Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteersDavid E Katz, Trinka S Coster, Marcia K Wolf, et al.
Journal of Manipulative and Physiological Therapeutics|June 21, 2023
Best Practices for Chiropractic Management of Adult Patients With Mechanical Low Back Pain: A Clinical Practice Guideline for Chiropractors in the United StatesWayne M Whalen, Cheryl Hawk, Ronald J Farabaugh, et al.
Infection and Immunity|March 16, 2002
Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneouslyFernando Güereña-Burgueño, Eric R Hall, David N Taylor, et al.
Environmental Microbiology|June 10, 2004
Occurrence and distribution of Vibrio cholerae in the coastal environment of PeruAna I Gil, Valérie R Louis, Irma N G Rivera, et al.
Vaccine|January 18, 2003
Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigenDavid E Katz, Arthur J DeLorimier, Marcia K Wolf, et al.
The Journal of Infectious Diseases|November 1, 2003
Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapyGiselle Soto, Christian T Bautista, Daniel E Roth, et al.
Journal of Clinical Microbiology|March 23, 2010
Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and MexicoHoonmo L Koo, Nadim J Ajami, Zhi-Dong Jiang, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Vaccine|May 13, 2008
Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidateRobin McKenzie, Malabi M Venkatesan, Marcia K Wolf, et al.
Vaccine|July 17, 2012
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune responseDavid N Taylor, John J Treanor, Eric A Sheldon, et al.
Infection and Immunity|March 16, 2002
Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccineMitchell B Cohen, Ralph A Giannella, Judy Bean, et al.
Infection and Immunity|January 27, 2004
Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteersDavid E Katz, Trinka S Coster, Marcia K Wolf, et al.
Journal of Manipulative and Physiological Therapeutics|June 21, 2023
Best Practices for Chiropractic Management of Adult Patients With Mechanical Low Back Pain: A Clinical Practice Guideline for Chiropractors in the United StatesWayne M Whalen, Cheryl Hawk, Ronald J Farabaugh, et al.
Infection and Immunity|March 16, 2002
Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneouslyFernando Güereña-Burgueño, Eric R Hall, David N Taylor, et al.
Environmental Microbiology|June 10, 2004
Occurrence and distribution of Vibrio cholerae in the coastal environment of PeruAna I Gil, Valérie R Louis, Irma N G Rivera, et al.
Vaccine|January 18, 2003
Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigenDavid E Katz, Arthur J DeLorimier, Marcia K Wolf, et al.
The Journal of Infectious Diseases|November 1, 2003
Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapyGiselle Soto, Christian T Bautista, Daniel E Roth, et al.
Journal of Clinical Microbiology|March 23, 2010
Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and MexicoHoonmo L Koo, Nadim J Ajami, Zhi-Dong Jiang, et al.
Pageof 5